Zentalis Pharmaceuticals, INC. (ZNTL) — DEF 14A Filings
All DEF 14A filings from Zentalis Pharmaceuticals, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Zentalis Pharma Files 2025 Proxy Statement
— Apr 30, 2025 Risk: medium
Zentalis Pharmaceuticals, Inc. filed a DEF 14A on April 30, 2025, detailing executive compensation and annual meeting information for the fiscal year ending Dec -
Zentalis Pharmaceuticals, Inc. DEF 14A Filing
— Apr 29, 2024 Risk: low
Zentalis Pharmaceuticals, Inc. (ZNTL) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Filing Type: DEF 14A. Reporting Period: 2024-06-21. File
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX